{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:13:17Z","timestamp":1785327197042,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shandong Medical and Health Technology Development Plan Project","award":["2017WS033"],"award-info":[{"award-number":["2017WS033"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802190"],"award-info":[{"award-number":["81802190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772412"],"award-info":[{"award-number":["81772412"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Fund Project of the Affiliated Hospital of Qingdao University","award":["2017"],"award-info":[{"award-number":["2017"]}]},{"name":"Shandong Provincial Science Foundation, China","award":["ZR2019BH084"],"award-info":[{"award-number":["ZR2019BH084"]}]},{"DOI":"10.13039\/501100002858","name":"Postdoctoral Science Foundation of China","doi-asserted-by":"crossref","award":["2019M652329"],"award-info":[{"award-number":["2019M652329"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taishan Scholars Program","award":["tsqn201909190"],"award-info":[{"award-number":["tsqn201909190"]}]},{"name":"Applied Basic Research Project of Qingdao","award":["19-6-2-51-cg"],"award-info":[{"award-number":["19-6-2-51-cg"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intervertebral disc degeneration (IVDD) is a primary cause of degenerative disc diseases; however, the mechanisms underlying the degeneration remain unclear. The immunoinflammatory response plays an important role in IVDD progression. The inflammatory cytokine lymphotoxin-\u03b1 (LT\u03b1), formerly known as TNF\u03b2, is associated with various pathological conditions, while its role in the pathogenesis of IVDD remains elusive.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Real-time quantitative polymerase chain reaction (RT-qPCR), Western blotting (WB), and enzyme-linked immunosorbent assays were used to assess the levels of LT\u03b1 in human nucleus pulposus (NP) tissues between degeneration and control groups. The plasma concentrations of LT\u03b1 and C-reactive protein (CRP) were compared between healthy and IVDD patients. Rat primary NP cells were cultured and identified via immunofluorescence. Methyl-thiazolyl-tetrazolium assays and flow cytometry were used to evaluate the effects of LT\u03b1 on rat NP cell viability. After NP cells were treated with LT\u03b1, degeneration-related molecules (Caspase-3, Caspase-1, matrix metalloproteinase (MMP) -3, aggrecan and type II collagen) were measured via RT-qPCR and WB.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The levels of both the mRNA and protein of LT\u03b1 in human degenerated NP tissue significantly increased. Plasma LT\u03b1 and CRP did not differ between healthy controls and IVDD patients. Rat primary NP cells were cultured, and the purity of primary NP cells was &gt;\u200990%. Cell experiments showed inversely proportional relationships among the LT\u03b1 dose, treatment time, and cell viability. The optimal conditions (dose and time) for LT\u03b1 treatment to induce rat NP cell degeneration were 5\u2009\u03bcg\/ml and 48\u2009~\u200972\u2009h. The apoptosis rate and the levels of Caspase-3, Caspase-1, and MMP-3 significantly increased after LT\u03b1 treatment, while the levels of type II collagen and aggrecan were decreased, and the protein expression levels were consistent with their mRNA expression levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrated that elevated LT\u03b1 is closely associated with IVDD and that LT\u03b1 may induce NP cell apoptosis and reduce important extracellular matrix (ECM) proteins, which cause adverse effects on IVDD progress. Moreover, the optimal conditions for LT\u03b1 treatment to induce NP cell degeneration were determined.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-020-03934-7","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T17:06:04Z","timestamp":1610557564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Elevated lymphotoxin-\u03b1 (TNF\u03b2) is associated with intervertebral disc degeneration"],"prefix":"10.1186","volume":"22","author":[{"given":"Zhu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chensheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Mecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1490-4871","authenticated-orcid":false,"given":"Bohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"issue":"7","key":"3934_CR1","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.joca.2015.03.028","volume":"23","author":"PP Vergroesen","year":"2015","unstructured":"Vergroesen PP, Kingma I, Emanuel KS, Hoogendoorn RJ, Welting TJ, van Royen BJ, van Die\u00ebn JH, Smit TH. Mechanics and biology in intervertebral disc degeneration: a vicious circle. Osteoarthritis Cartilage. 2015;23(7):1057\u201370.","journal-title":"Osteoarthritis Cartilage"},{"issue":"9178","key":"3934_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(99)01312-4","volume":"354","author":"GB Andersson","year":"1999","unstructured":"Andersson GB. Epidemiological features of chronic low-back pain. Lancet. 1999;354(9178):581\u20135.","journal-title":"Lancet"},{"issue":"14","key":"3934_CR3","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1097\/01.brs.0000222032.52336.8e","volume":"31","author":"M Haefeli","year":"2006","unstructured":"Haefeli M, Kalberer F, Saegesser D, Nerlich AG, Boos N, Paesold G. The course of macroscopic degeneration in the human lumbar intervertebral disc. Spine (Phila Pa 1976). 2006;31(14):1522\u201331.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1","key":"3934_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4184\/asj.2009.3.1.39","volume":"3","author":"Y-S Choi","year":"2009","unstructured":"Choi Y-S. Pathophysiology of Degenerative Disc Disease. Asian Spine J. 2009;3(1):39\u201344.","journal-title":"Asian Spine J"},{"issue":"Suppl 2","key":"3934_CR5","first-page":"3","volume":"88","author":"MC Batti\u00e9","year":"2006","unstructured":"Batti\u00e9 MC, Videman T. Lumbar disc degeneration: epidemiology and genetics. J Bone Joint Surg Am. 2006;88(Suppl 2):3\u20139.","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"3934_CR6","first-page":"1009","volume":"6","author":"Z Sun","year":"2013","unstructured":"Sun Z, Zhang M, Zhao XH, Liu ZH, Gao Y, Samartzis D, Wang HQ, Luo ZJ. Immune cascades in human intervertebral disc: the pros and cons. Int J Clin Exp Pathol. 2013;6(6):1009\u201314.","journal-title":"Int J Clin Exp Pathol"},{"key":"3934_CR7","doi-asserted-by":"crossref","unstructured":"Robinson D, Mirovsky Y, Halperin N, Evron Z and Nevo Z. Changes in proteoglycans of intervertebral disc in diabetic patients. A possible cause of increased back pain. Spine (Phila Pa 1976) 1998; 23(8): 849\u201355; discussion 856.","DOI":"10.1097\/00007632-199804150-00001"},{"issue":"2","key":"3934_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00776-005-0987-4","volume":"11","author":"Y Nemoto","year":"2006","unstructured":"Nemoto Y, Matsuzaki H, Tokuhasi Y, Okawa A, Uematu Y, Nishimura T, Oda H. Histological changes in intervertebral discs after smoking and cessation: experimental study using a rat passive smoking model. J Orthop Sci. 2006;11(2):191\u20137.","journal-title":"J Orthop Sci"},{"issue":"5","key":"3934_CR9","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1016\/j.wneu.2012.06.010","volume":"80","author":"WM Erwin","year":"2013","unstructured":"Erwin WM, Fehlings MG. Intervertebral disc degeneration: genes hold the key. World neurosurgery. 2013;80(5):e131\u20133.","journal-title":"World neurosurgery"},{"issue":"6","key":"3934_CR10","first-page":"523","volume":"32","author":"SE Navone","year":"2017","unstructured":"Navone SE, Marfia G, Giannoni A, Beretta M, Guarnaccia L, Gualtierotti R, Nicoli D, Rampini P, Campanella R. Inflammatory mediators and signalling pathways controlling intervertebral disc degeneration. Histol Histopathol. 2017;32(6):523\u201342.","journal-title":"Histol Histopathol"},{"issue":"3","key":"3934_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","volume":"119","author":"BB Aggarwal","year":"2012","unstructured":"Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood. 2012;119(3):651\u201365.","journal-title":"Blood"},{"issue":"17","key":"3934_CR12","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1097\/01.brs.0000176188.40263.f9","volume":"30","author":"CA S\u00e9guin","year":"2005","unstructured":"S\u00e9guin CA, Pilliar RM, Roughley PJ, Kandel RA. Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine (Phila Pa 1976). 2005;30(17):1940\u20138.","journal-title":"Spine (Phila Pa 1976)"},{"key":"3934_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev.immunol.23.021704.115719","volume":"23","author":"CF Ware","year":"2005","unstructured":"Ware CF. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol. 2005;23:787\u2013819.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"3934_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cytogfr.2014.02.001","volume":"25","author":"NH Ruddle","year":"2014","unstructured":"Ruddle NH. Lymphotoxin and TNF: how it all began-a tribute to the travelers. Cytokine Growth Factor Rev. 2014;25(2):83\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"3934_CR15","doi-asserted-by":"publisher","first-page":"R202","DOI":"10.1186\/ar4393","volume":"15","author":"C Buhrmann","year":"2013","unstructured":"Buhrmann C, Shayan P, Aggarwal BB, Shakibaei M. Evidence that TNF-\u03b2 (lymphotoxin \u03b1) can activate the inflammatory environment in human chondrocytes. Arthritis Res Ther. 2013;15(6):R202.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3934_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1182\/blood-2009-01-199927","volume":"115","author":"KA Markey","year":"2010","unstructured":"Markey KA, Burman AC, Banovic T, Kuns RD, Raffelt NC, Rowe V, Olver SD, Don AL, Morris ES, Pettit AR, Wilson YA, Robb RJ, Randall LM, Korner H, Engwerda CR, Clouston AD, Macdonald KP, Hill GR. Soluble lymphotoxin is an important effector molecule in GVHD and GVL. Blood. 2010;115(1):122\u201332.","journal-title":"Blood"},{"issue":"1","key":"3934_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12891-020-03329-8","volume":"21","author":"C Qiu","year":"2020","unstructured":"Qiu C, Wu X, Bian J, Ma X, Zhang G, Guo Z, Wang Y, Ci Y, Wang Q, Xiang H, Chen B. Differential proteomic analysis of fetal and geriatric lumbar nucleus pulposus: immunoinflammation and age-related intervertebral disc degeneration. BMC musculoskeletal disorders. 2020;21(1):339.","journal-title":"BMC musculoskeletal disorders"},{"issue":"17","key":"3934_CR18","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1097\/00007632-200109010-00011","volume":"26","author":"CW Pfirrmann","year":"2001","unstructured":"Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976). 2001;26(17):1873\u20138.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"9","key":"3934_CR19","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00276-018-2048-7","volume":"40","author":"AH Fyllos","year":"2018","unstructured":"Fyllos AH, Arvanitis DL, Karantanas AH, Varitimidis SE, Hantes M, Zibis AH. Magnetic resonance morphometry of the adult normal lumbar intervertebral space. Surg Radiol Anat. 2018;40(9):1055\u201361.","journal-title":"Surg Radiol Anat"},{"key":"3934_CR20","unstructured":"Yu B WY, Qiu GX. Research process on evaluation methods of MRI grading system for intervertebral disc degeneration. Chinese Journal of Bone and Joint Surgery 2010; 3(5):410\u20133. http:\/\/kns.cnki.net\/kcms\/detail\/detail.aspx?dbcode=CJFD&filename=ZGJW201005021&dbname=CJFD2010. In Chinese."},{"key":"3934_CR21","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.2147\/IJN.S157463","volume":"13","author":"Z Chen","year":"2018","unstructured":"Chen Z, Zhao M, Zhang J, Zhou K, Ren X, Mei X. Construction of injectable, pH sensitive, antibacterial, mineralized amino acid yolk-shell microspheres for potential minimally invasive treatment of bone infection. Int J Nanomedicine. 2018;13:3493\u2013506.","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"3934_CR22","first-page":"452","volume":"67","author":"L Le Gars","year":"2000","unstructured":"Le Gars L, Borderie D, Kaplan G, Berenbaum F. Systemic inflammatory response with plasma C-reactive protein elevation in disk-related lumbosciatic syndrome. Joint Bone Spine. 2000;67(5):452\u20135.","journal-title":"Joint Bone Spine"},{"issue":"5","key":"3934_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.4184\/asj.2016.10.5.843","volume":"10","author":"B Zu","year":"2016","unstructured":"Zu B, Pan H, Zhang XJ, Yin ZS. Serum Levels of the Inflammatory Cytokines in Patients with Lumbar Radicular Pain Due to Disc Herniation. Asian Spine J. 2016;10(5):843\u20139.","journal-title":"Asian Spine J"},{"issue":"6","key":"3934_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00011-018-1139-6","volume":"67","author":"T Hirose","year":"2018","unstructured":"Hirose T, Fukuma Y, Takeshita A, Nishida K. The role of lymphotoxin-\u03b1 in rheumatoid arthritis. Inflamm Res. 2018;67(6):495\u2013501.","journal-title":"Inflamm Res"},{"issue":"11","key":"3934_CR25","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/rheumatology\/kep262","volume":"48","author":"J Clouet","year":"2009","unstructured":"Clouet J, Grimandi G, Pot-Vaucel M, Masson M, Fellah HB, Guigand L, Cherel Y, Bord E, Rannou F, Weiss P, Guicheux J, Vinatier C. Identification of phenotypic discriminating markers for intervertebral disc cells and articular chondrocytes. Rheumatology (Oxford). 2009;48(11):1447\u201350.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3934_CR26","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3892\/ijmm.2016.2573","volume":"37","author":"F Zhang","year":"2016","unstructured":"Zhang F, Zhao X, Shen H, Zhang C. Molecular mechanisms of cell death in intervertebral disc degeneration (Review). Int J Mol Med. 2016;37(6):1439\u201348.","journal-title":"Int J Mol Med"},{"issue":"2","key":"3934_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","volume":"6","author":"AG Porter","year":"1999","unstructured":"Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6(2):99\u2013104.","journal-title":"Cell Death Differ"},{"issue":"11","key":"3934_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1745-7270.2005.00108.x","volume":"37","author":"TJ Fan","year":"2005","unstructured":"Fan TJ, Han LH, Cong RS, Liang J. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai). 2005;37(11):719\u201327.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"4","key":"3934_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/ar.23059","volume":"298","author":"ZH Chen","year":"2015","unstructured":"Chen ZH, Jin SH, Wang MY, Jin XL, Lv C, Deng YF, Wang JL. Enhanced NLRP3, caspase-1, and IL-1beta levels in degenerate human intervertebral disc and their association with the grades of disc degeneration. Anat Rec (Hoboken). 2015;298(4):720\u20136.","journal-title":"Anat Rec (Hoboken)"},{"key":"3934_CR30","doi-asserted-by":"crossref","unstructured":"Le Maitre CL, Pockert A, Buttle DJ, Freemont AJ and Hoyland JA. Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans 2007; 35(Pt 4): 652\u2013655.","DOI":"10.1042\/BST0350652"},{"issue":"11","key":"3934_CR31","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00586-009-1031-8","volume":"18","author":"BE Bachmeier","year":"2009","unstructured":"Bachmeier BE, Nerlich A, Mittermaier N, Weiler C, Lumenta C, Wuertz K, Boos N. Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration. Eur Spine J. 2009;18(11):1573\u201386.","journal-title":"Eur Spine J"},{"issue":"3","key":"3934_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/jor.22732","volume":"33","author":"H Liu","year":"2015","unstructured":"Liu H, Pan H, Yang H, Wang J, Zhang K, Li X, Wang H, Ding W, Li B, Zheng Z. LIM mineralization protein-1 suppresses TNF-alpha induced intervertebral disc degeneration by maintaining nucleus pulposus extracellular matrix production and inhibiting matrix metalloproteinases expression. J Orthop Res. 2015;33(3):294\u2013303.","journal-title":"J Orthop Res"},{"key":"3934_CR33","doi-asserted-by":"crossref","unstructured":"Krupkova O, Hlavna M, Amir Tahmasseb J, Zvick J, Kunz D, Ito K, Ferguson SJ, Wuertz-Kozak K. An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate. Int J Mol Sci 2016; 17(10), pii: E1640.","DOI":"10.3390\/ijms17101640"},{"issue":"10","key":"3934_CR34","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1182\/blood.V85.10.2779.bloodjournal85102779","volume":"85","author":"Z Qin","year":"1995","unstructured":"Qin Z, van Tits LJ, Buurman WA, Blankenstein T. Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice. Blood. 1995;85(10):2779\u201385.","journal-title":"Blood"},{"issue":"3","key":"3934_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/00002281-200205000-00002","volume":"14","author":"LG Criscione","year":"2002","unstructured":"Criscione LG, St Clair EW. Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases. Curr Opin Rheumatol. 2002;14(3):204\u201311.","journal-title":"Curr Opin Rheumatol"},{"key":"3934_CR36","doi-asserted-by":"crossref","unstructured":"Evashwick-Rogler TW, Lai A, Watanabe H, Salandra JM, Winkelstein BA, Cho SK, Hecht AC, Iatridis JC. Inhibiting tumor necrosis factor-alpha at time of induced intervertebral disc injury limits long-term pain and degeneration in a rat model. JOR spine 2018; 1(2), pii: e1014.","DOI":"10.1002\/jsp2.1014"},{"issue":"4","key":"3934_CR37","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1136\/ard.2010.139774","volume":"70","author":"MM Soliman","year":"2011","unstructured":"Soliman MM, Ashcroft DM, Watson KD, Lunt M, Symmons DP, Hyrich KL. Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2011;70(4):583\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3934_CR38","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1136\/ard.2003.014878","volume":"63","author":"MH Buch","year":"2004","unstructured":"Buch MH, Conaghan PG, Quinn MA, Bingham SJ, Veale D, Emery P. True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha? Ann Rheum Dis. 2004;63(10):1344\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3934_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00586-015-4089-5","volume":"25","author":"I Sitte","year":"2016","unstructured":"Sitte I, Klosterhuber M, Lindtner RA, Freund MC, Neururer SB, Pfaller K, Kathrein A. Morphological changes in the human cervical intervertebral disc post trauma: response to fracture-type and degeneration grade over time. Eur Spine J. 2016;25(1):80\u201395.","journal-title":"Eur Spine J"},{"issue":"17","key":"3934_CR40","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/01.BRS.0000176445.01967.8a","volume":"30","author":"H Xu","year":"2005","unstructured":"Xu H, Qiu G, Wu Z, Wang Y, Zhang J, Liu Y, Yang X. Expression of transforming growth factor and basic fibroblast growth factor and core protein of proteoglycan in human vertebral cartilaginous endplate of adolescent idiopathic scoliosis. Spine (Phila Pa 1976). 2005;30(17):1973\u20138.","journal-title":"Spine (Phila Pa 1976)"},{"key":"3934_CR41","doi-asserted-by":"crossref","unstructured":"Rodrigues LMR, Oliveira LZ, Silva M, Accardo CM, Giglio ABD, Pinhal M. Inflammatory biomarkers in sera of patients with intervertebral disc degeneration. Einstein (Sao Paulo) 2019; 17(4): eAO4637.","DOI":"10.31744\/einstein_journal\/2019AO4637"},{"issue":"11","key":"3934_CR42","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1111\/jcmm.13828","volume":"22","author":"K Suyama","year":"2018","unstructured":"Suyama K, Sakai D, Hirayama N, Nakamura Y, Matsushita E, Terayama H, Qu N, Tanaka O, Sakabe K, Watanabe M. Effects of interleukin-17A in nucleus pulposus cells and its small-molecule inhibitors for intervertebral disc disease. J Cell Mol Med. 2018;22(11):5539\u201351.","journal-title":"J Cell Mol Med"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03934-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-020-03934-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03934-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T05:06:46Z","timestamp":1610600806000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-020-03934-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3934"],"URL":"https:\/\/doi.org\/10.1186\/s12891-020-03934-7","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out following the Declaration of Helsinki and approved by the ethics committee of Affiliated Hospital of Qingdao University (QDFY WZ 2018-3-1-02). Written informed consent was obtained from all participants in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}